Cardlytics (NASDAQ:CDLX) reported quarterly sales of $73.996 million which beat the analyst consensus estimate of $63.627 million by 16.30 percent. This is a 17.01 percent decrease over sales of $89.167 million the same period last year.
Cardlytics (NASDAQ:CDLX) reported quarterly sales of $73.996 million which beat the analyst consensus estimate of $63.627 million by 16.30 percent. This is a 17.01 percent decrease over sales of $89.167 million the same period last year.
Comments